Kouyama Y - Search Results

1

The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.

Morioka H, Hirabayashi A, Iguchi M, Tomita Y, Kato D, Sato N, Hyodo M, Kawamura N, Sadomoto T, Ichikawa K, Inagaki T, Kato Y, Kouyama Y, Ito Y, Yagi T. Morioka H, et al. Among authors: kouyama y. Am J Infect Control. 2016 Jul 1;44(7):e119-23. doi: 10.1016/j.ajic.2016.03.045. Am J Infect Control. 2016. PMID: 27372390

2

Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.

Hirabayashi A, Kato D, Tomita Y, Iguchi M, Yamada K, Kouyama Y, Morioka H, Tetsuka N, Yagi T. Hirabayashi A, et al. Among authors: kouyama y. J Med Microbiol. 2017 Nov;66(11):1562-1572. doi: 10.1099/jmm.0.000601. Epub 2017 Oct 6. J Med Microbiol. 2017. PMID: 28984565

3

Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.

Morioka H, Iguchi M, Tetsuka N, Kinoshita F, Tomita Y, Kato D, Hirabayashi A, Matsumoto A, Oka K, Kato H, Inagaki T, Kato Y, Kitagawa K, Ichikawa K, Kouyama Y, Kawamura N, Toyodome Y, Adachi N, Ito Y, Yagi T. Morioka H, et al. Among authors: kouyama y. Infect Prev Pract. 2021 Jun 4;3(3):100151. doi: 10.1016/j.infpip.2021.100151. eCollection 2021 Sep. Infect Prev Pract. 2021. PMID: 34647007 Free PMC article.

4

Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).

Ishii Y, Ueda C, Kouyama Y, Tateda K, Yamaguchi K. Ishii Y, et al. Among authors: kouyama y. Diagn Microbiol Infect Dis. 2011 Apr;69(4):443-8. doi: 10.1016/j.diagmicrobio.2010.10.033. Diagn Microbiol Infect Dis. 2011. PMID: 21396543

5

Genotyping of skin and soft tissue infection (SSTI)-associated methicillin-resistant Staphylococcus aureus (MRSA) strains among outpatients in a teaching hospital in Japan: application of a phage-open reading frame typing (POT) kit.

Maeda T, Saga T, Miyazaki T, Kouyama Y, Harada S, Iwata M, Yoshizawa S, Kimura S, Ishii Y, Urita Y, Sugimoto M, Yamaguchi K, Tateda K. Maeda T, et al. Among authors: kouyama y. J Infect Chemother. 2012 Dec;18(6):906-14. doi: 10.1007/s10156-012-0506-4. Epub 2012 Nov 13. J Infect Chemother. 2012. PMID: 23150115

6

Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates.

Harada S, Ishii Y, Saga T, Kouyama Y, Tateda K, Yamaguchi K. Harada S, et al. Among authors: kouyama y. Antimicrob Agents Chemother. 2012 Feb;56(2):1093-6. doi: 10.1128/AAC.00258-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106217 Free PMC article.

7

The impact of carbapenem shortage and stewardship countermeasures on antimicrobial practice at a tertiary care center.

Kouyama Y, Uehara Y, Takamatsu A, Suzuki R, Nishida R, Inuzuka K, Muramatsu E, Ohyama K, Doi Y, Yamada S, Honda H. Kouyama Y, et al. Antimicrob Steward Healthc Epidemiol. 2023 Oct 19;3(1):e173. doi: 10.1017/ash.2023.460. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38028913 Free PMC article.

8

Characterization of Klebsiella pneumoniae producing SHV-12 and DHA-1 beta-lactamases accompanied by carbapenem resistance during hospitalization in a chronic care ward in Japan.

Yamada Y, Ishii Y, Kouyama Y, Katho M, Odashiro R, Yamahata K, Tateda K, Yamaguchi K, Suwabe A. Yamada Y, et al. Among authors: kouyama y. J Chemother. 2009 Aug;21(4):445-7. doi: 10.1179/joc.2009.21.4.445. J Chemother. 2009. PMID: 19622465 No abstract available.

9

Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man.

Kunimasa K, Ishida T, Kimura S, Tanaka M, Kouyama Y, Yamashita S, Morita M, Tachibana H, Tokioka F, Ito A, Sumi C, Tateda K. Kunimasa K, et al. Among authors: kouyama y. Intern Med. 2012;51(17):2473-8. doi: 10.2169/internalmedicine.51.7596. Epub 2012 Sep 1. Intern Med. 2012. PMID: 22975571 Free article.

10

A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.

Mori N, Ishii Y, Tateda K, Kimura S, Kouyama Y, Inoko H, Mitsunaga S, Yamaguchi K, Yoshihara E. Mori N, et al. Among authors: kouyama y. J Antimicrob Chemother. 2012 Sep;67(9):2173-81. doi: 10.1093/jac/dks174. Epub 2012 May 24. J Antimicrob Chemother. 2012. PMID: 22628248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters